The Asia equity derivatives arm of BNP Paribas is advising investors to act on the limited correction by buying Chinese equities on the dip, in the wake of MSCI’s decision not to include China A-shares in its influential emerging markets index. According to the unit’s head, Guillaum Derville, the market may “buy the rumour” and “sell the facts”, which could…
Buy on Chinese equity dip after MSCI A-share rejection, say BNP Paribas
Have a confidential tip? Get in touch [email protected]



